Travel Grant Japan/Korea, Nordic health Summit, April 23-20

Important results from the project

Yes, the key objective was to initiate and/or continue dialogue with potential partners in Japan and Korea for potential future development and commercialisation collaborations for our two in-house developed drug candidates. The project enabled us to deepen previous discussions and establish discussions with new companies we hadn´t met before, especially within our new are of focus, rare bone-related disorders.

Expected long term effects

Formalized partnership agreements with the objective to develop and commercialize our 2 lead candidates.

Approach and implementation

Participation in match-making activities in both Japan and Korea, supported by Business Sweden locally in each country. 1-1 meetings with relevant companies from Japan and Korea respectively.

External links

Hemsida för läkemedelskandidatem vi primär levercancer